Abstract

Heart failure with preserved ejection fraction (HFpEF) is characterized by signs and symptoms of heart failure in the presence of a normal left ventricular ejection fraction. Although it accounts for up to 50% of all clinical presentations of heart failure, there are no evidence-based therapies for HFpEF to reduce morbidity and mortality. Additionally there is a lack of mechanistic understanding about the pathogenesis of HFpEF. HFpEF is associated with many comorbidities (such as obesity, hypertension, type 2 diabetes, atrial fibrillation, etc.) and is coupled with both cardiac and extra-cardiac abnormalities. Large outcome trials and registries reveal that being obese is a major risk factor for HFpEF. There is increasing focus on investigating the link between obesity and HFpEF, and the role that the adipose tissue and the heart, and the circulating milieu play in development and pathogenesis of HFpEF. This review discusses features of the obese-HFpEF phenotype and highlights proposed mechanisms implicated in the inter-tissue communication between adipose tissue and the heart in obesity-associated HFpEF.

Highlights

  • Reviewed by: Petra Kienesberger, Dalhousie University, Canada Salvatore Carbone, Virginia Commonwealth University, United States Sergio Martinez Hervas, University of Valencia, Spain

  • It accounts for up to 50% of all clinical presentations of heart failure, there are no evidence-based therapies for Heart failure with preserved ejection fraction (HFpEF) to reduce morbidity and mortality

  • HFpEF is associated with many comorbidities and is coupled with both cardiac and extra-cardiac abnormalities

Read more

Summary

Obesity and Exercise Tolerance in HFpEF

Decreased exercise tolerance is an early symptom of HFpEF and is a major determinant of prognosis and associates with a reduction in quality of life [83]. The pattern of regional adipose deposition, with increased intra-abdominal and intermuscular fat appear to associate with decreased peak VO2, and may be related to adverse consequences in exercise tolerance in HFpEF beyond total body adiposity [87]. A recent study demonstrated that exercise training improved exercise capacity and body composition, with a reduction in total fat mass and thigh muscle/inter-muscular fat ratio, and with reduced inflammation and LV mass [92]. Preclinical studies in obese HFpEF rats showed that exercise training improved exercise capacity [36]. Further studies are warranted in order to investigate specific mechanisms involved

The Obesity Paradox
Cardiac Natriuretic Peptides and Obesity in HFpEF
The Natriuretic Handicap
Cardiac Natriuretic Peptides Signaling in the Adipose Tissue
Findings
CONCLUDING REMARKS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call